loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Open ICICI
3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

+91

BLOG

Torrent Pharmaceuticals has recalled select batches of Semalix Injection

ICICIdirect Research 10 Jul 2026 DISCLAIMER

News: Torrent Pharmaceuticals has recalled select batches of Semalix Injection 2 mg and 4 mg, manufactured by Dr. Reddy's Laboratories, after certain batches of semaglutide failed quality specifications due to an issue with the active pharmaceutical ingredient (API). The recall is limited to the affected batches, while all other Semalix products, including tablets, the 8 mg Semalix injection manufactured by MSN Laboratories, and Sembolic reusable injection manufactured by Zydus Lifesciences, remain available. Torrent said it is investigating the root cause and implementing corrective measures to ensure product quality

View: Unlike DRL, the impact on the sales is expected to be minimal. Torrent is currently selling Semaglutide only in India ( monthly sales ~Rs 15-16 crore) and the sourcing is from three different partners for different strength and drug delivery (plus in-house manufacturing of two strengths). 

Impact: Neutral

Download ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere

Download ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere